Manning Meredith — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Manning Meredith has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $229K.

Profile

Meredith Manning is the Chief Commercial Officer of Soleno Therapeutics Inc. (SLNO), as indicated in the SEC filing with CIK 0001752631 dated 2026-01-23. The filing shows zero equity purchases or sales for her, confirming the executive role within Soleno, a biopharmaceutical company focused on developing therapies for rare diseases, including the DCCR (diazoxide choline) program.

Board memberships

• Soleno Therapeutics Inc.

Awards & honors

• Not disclosed in SEC filing
• Role confirms leadership in Soleno's commercial strategy as CCO

Recent Transactions

Companies — Last 90 Days

• SOLENO THERAPEUTICS INC (SLNO) — 1 filings, last 2026-05-18

Frequently Asked Questions

Who is Manning Meredith?

Meredith Manning is the Chief Commercial Officer of Soleno Therapeutics Inc. (SLNO), as indicated in the SEC filing with CIK 0001752631 dated 2026-01-23. The filing shows zero equity purchases or sales for her, confirming the executive role within Soleno, a biopharmaceutical company focused on developing therapies for rare diseases, including the DCCR (diazoxide choline) progra…

How many SEC Form 4 filings has Manning Meredith submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Manning Meredith been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($229K) across all tracked filings.

Where can I see all of Manning Meredith's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week